Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2641603013 | Ranibizumab (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 2645709013 | Ranibizumab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3523203019 | Product containing ranibizumab (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3523204013 | Product containing ranibizumab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3668541010 | Ranibizumab product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3716427010 | Ranibizumab-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ranibizumab-containing product | Is a | Angiogenesis inhibitor-containing product | true | Inferred relationship | Some | ||
| Ranibizumab-containing product | Is a | Monoclonal antibody-containing product | true | Inferred relationship | Some | ||
| Ranibizumab-containing product | Has active ingredient | Ranibizumab | true | Inferred relationship | Some | 1 | |
| Ranibizumab-containing product | Is a | Drugs used in the eye | false | Inferred relationship | Some | ||
| Ranibizumab-containing product | Has manufactured dose form | Ocular dose form | false | Inferred relationship | Some | ||
| Ranibizumab-containing product | Is a | Product manufactured as ocular dose form | false | Inferred relationship | Some | ||
| Ranibizumab-containing product | Has active ingredient | Angiogenesis inhibitor | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ranibizumab only product | Is a | True | Ranibizumab-containing product | Inferred relationship | Some | |
| Ranibizumab-containing product in parenteral dose form | Is a | True | Ranibizumab-containing product | Inferred relationship | Some | |
| Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial | Is a | False | Ranibizumab-containing product | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR